Shawn Egan

Stock Analyst at Citigroup

(1.97)
# 3,137
Out of 5,044 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $40.29
Upside: -57.81%